Annovis Bio Inc (ANVS)
NYSE
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -381.006 | -349.144 | -169.692 | -118.276 | -53.536 | -61.76 | -243.149 |
Return on Equity (%) | 19.581 | 9.808 | 12.257 | 1055.459 | -55.681 | -69.567 | -546.386 |
Return on Invested Capital (%) | 1033.333 | 220.031 | 170.201 | -215.165 | -55.873 | -70.07 | -437.807 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.493 | -1.827 | -5.3 | 1.094 | 5.493 | 3.469 | -0.755 |
Earnings Per Share | -2.545 | -2.523 | -3.502 | -0.793 | -1.788 | -3.103 | -5.477 |
Cash Per Share | 1.295 | 0.124 | 0.007 | 1.172 | 5.64 | 3.476 | 0.561 |
Working Capital Per Share | -0.493 | -1.827 | -4.463 | 1.094 | 5.493 | 3.469 | 0.578 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.545 | -2.523 | -3.502 | -0.793 | -1.788 | -3.103 | -5.477 |
EBITDA Per Share | -2.545 | -2.523 | -3.502 | -0.793 | -1.788 | -3.103 | -5.477 |
Free Cash Flow Per Share | -2.545 | -2.523 | -3.502 | -0.793 | -1.788 | -3.103 | -5.477 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 268k | 283k | 283k | 6.89M | 8.1M | N/A | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | N/A | 8.16M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 113.96M |
Price to Earnings Ratio | -2.02 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 19.69 |
Price to Book Ratio | -14.62 |
Dividend Yield | - |
Shares Outstanding | 13.05M |
Average Volume (1 week) | 185.44k |
Average Volume (1 Month) | 352.16k |
52 Week Change | 35.89% |
52 Week High | 22.49 |
52 Week Low | 4.53 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.